Infusion Pumps – Market Insights – United States

The COVID-19 pandemic has had a negative impact on the growth of the US infusion pump market in the short term. However, the market would be mainly driven by introduction of new technologies, trends like remote patient monitoring and the adoption of innovative products such as hybrid close-loop insulin pumps and smart infusion pumps enabled with HCIT features. These advanced products are expected to command a higher price and contribute to moderate growth over the forecast period.

This Medtech 360 Report offers thorough information and comprehensive analysis on the state of the infusion pump market in the US from 2019 through 2032.

The infusion pump market was affected by the COVID-19 pandemic.

How has the COVID-19 pandemic affected the demand for infusion pumps in the US?

In what ways have the impact of COVID-19 varied across different segments of the infusion pump market?

How long will each segment be affected by the impact of COVID-19?

When can we expect the market to reach the levels that existed before the pandemic?

The modifications in reimbursement patterns are affecting healthcare providers and patients.

How are the new regulations affecting the market?

Which segment of infusion pumps is affected the most?

What are the changes in trends being seen due to the new reimbursement policies?

Technological advancements and innovative insulin pump device space will drive market growth.

What is the effect of introducing the hybrid closed-loop insulin pump system on market?

What companies are likely to capitalize on the expanding market and seek out new opportunities?

Various strategies are being employed to gain market share and increase unit sales.

Who are the top players in each device market?

What are the competitive advantages of the various leading competitors?

What is their future market outlook?

Which players are looking to expand their product portfolios?

Table of contents